News

Alongside second-quarter results (a 1.9% drop in comparable sales and a 100-basis-point erosion in gross margin to 29%), ...
Dow Jones Top Markets Headlines at 1 PM ET: Trump Considers Firing Fed Official After Accusation of Mortgage Fraud | Nasdaq ... Trump Considers Firing Fed Official After Accusation of Mortgage Fraud ...
T.J. Maxx parent TJX Cos. raised its full-year profit outlook after logging higher-than-expected earnings and sales in the latest quarter, as consumers flocked to the company's stores in search of ...
Shares of Alcon fell after the company posted a lower second-quarter profit and cut its full-year sales outlook, saying it expected a full-year tariff impact of $100 million. The stock was down 9.1% ...
Osmond, a Connecticut resident, gave up buying lottery tickets more than a decade ago after losing around $1 million on various games, be they scratch-offs or drawings. He told MarketWatch that his ...
Lan Anh Tran: The search for well-constructed high dividend yield ETFs can be fraught with difficult choices. The classic ...
Carvana's stock was down 3.7% in early-afternoon trading. It has now slumped about 15% since closing at a record $390.17 on July 31 following that positive second-quarter report.
The STOXX Europe 600 Index is up 1.28 points or 0.23% today to 559.09 --Largest three day point and percentage gain since Friday, Aug. 15, 2025 ...
Alcon Down Over 9%, On Track for Largest Percent Decrease Since March 2020 — Data Talk Alcon AG (ALC) is currently at $81.54, down $8.58 or 9.52% --Would be lowest close since May 13, 2024, when it ...
Dow Jones Top Energy Headlines at 11 AM ET: Oil Prices Recover Ground on Inventory Drawdown But Outlook Is Bearish | NorthWestern ... Oil Prices Recover Ground on Inventory Drawdown But Outlook Is ...
After underperforming the market Tuesday, Constellation Software led the gainers board with a rise of 1.2%. Among heavy-weight downturns, consumer lender Goeasy declined 1.5% after it closed a ...
Doustdar, a longtime company insider, took up the chief executive role on Aug. 7, a week after Novo Nordisk cut its outlook for the second time this year blaming competition from copycat versions of ...